{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:51:26Z","timestamp":1791481886041,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["312433\/2023-9"],"award-info":[{"award-number":["312433\/2023-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Finep","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-05218-23"],"award-info":[{"award-number":["APQ-05218-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-01305-24"],"award-info":[{"award-number":["APQ-01305-24"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["RED-00116-23"],"award-info":[{"award-number":["RED-00116-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-00544-23"],"award-info":[{"award-number":["APQ-00544-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.xphs.2026.104519","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:25:32Z","timestamp":1790519132000},"page":"104519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Solid state convergence to fluconazole monohydrate: Mechanochemical hydration, phase transitions, and solvent\u2011mediated conversion driving solubility"],"prefix":"10.1016","volume":"115","author":[{"given":"Edeilson Vitor","family":"Gonzaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Godoi","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8323-1984","authenticated-orcid":false,"given":"Ol\u00edmpia Maria Martins Santos","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Cesar","family":"Candido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marillia Castilho Silva","family":"Toti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali Benjamin","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2467-9957","authenticated-orcid":false,"given":"Person Pereira","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Terra","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2726-1265","authenticated-orcid":false,"given":"Ant\u00f4nio Carlos","family":"Doriguetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104519_bib0001","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s11095-023-03573-2","article-title":"Solid form screenings in pharmaceutical development: a perspective on current practices","volume":"40","author":"Gui","year":"2023","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104519_bib0002","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1039\/D4CE00811A","article-title":"Polymorph transformation of solid drugs and inhibiting strategies","volume":"26","author":"Feng","year":"2024","journal-title":"CrysEngComm"},{"key":"10.1016\/j.xphs.2026.104519_bib0003","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40005-021-00556-6","article-title":"Tableting process-induced solid-state polymorphic transition","volume":"52","author":"Park","year":"2022","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.xphs.2026.104519_bib0004","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.3390\/ijms23169013","article-title":"The relevance of crystal forms in the pharmaceutical field: sword of Damocles or innovation tools?","volume":"23","author":"Braga","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2026.104519_bib0005","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1023\/A:1011052932607","article-title":"An extraordinary example of conformational polymorphism","volume":"18","author":"Bauer","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104519_bib0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1877946813666230822113606","article-title":"Drug polymorphism: an important pre-formulation tool in the formulation development of a dosage form","volume":"14","author":"Singh","year":"2024","journal-title":"Curr Phys Chem"},{"key":"10.1016\/j.xphs.2026.104519_bib0007","first-page":"10","article-title":"Polymorphism: the phenomenon affecting the performance of drugs","volume":"1","author":"Raza","year":"2014","journal-title":"SOJ Pharm Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104519_bib0008","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11094-025-03443-8","article-title":"Practical and regulatory aspects of the study and control of polymorphism in pharmaceutical development (Review)","volume":"59","author":"Sergeeva","year":"2025","journal-title":"Pharm Chem J"},{"key":"10.1016\/j.xphs.2026.104519_bib0009","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/acs.molpharmaceut.1c00752","article-title":"Directing crystallization outcomes of conformationally flexible molecules: polymorphs, solvates, and desolvation pathways of fluconazole","volume":"19","author":"Nowak","year":"2022","journal-title":"Mol. Pharm"},{"key":"10.1016\/j.xphs.2026.104519_bib0010","first-page":"697","article-title":"Enhancing the solubility of fluconazole using a new essential oil based microemulsion system","volume":"5","author":"Nirmala","year":"2013","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104519_bib0011","doi-asserted-by":"crossref","first-page":"44317","DOI":"10.1039\/C5RA05423K","article-title":"Complexes of fluconazole with sodium p-sulfonatocalix[n]arenes: characterization, solubility and antifungal activity","volume":"5","author":"Abranches","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2026.104519_bib0012","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3390\/molecules29122855","article-title":"Fluconazole analogs and derivatives: an overview of synthesis, chemical transformations, and biological activity","volume":"29","author":"Janowski","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2026.104519_bib0013","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1081\/PDT-120015052","article-title":"Solid-State characterization of fluconazole","volume":"7","author":"Alkhamis","year":"2002","journal-title":"Pharm Dev Thecnol"},{"key":"10.1016\/j.xphs.2026.104519_bib0014","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1021\/cg1010117","article-title":"Fluconazole cocrystals with dicarboxylic acids","volume":"10","author":"Kastelic","year":"2010","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2026.104519_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcrysgro.2014.08.007","article-title":"Exploration of crystal simulation potential by fluconazole isomorphism and its application in improvement of pharmaceutical properties","volume":"406","author":"Thakur","year":"2014","journal-title":"J Cryst Growth"},{"key":"10.1016\/j.xphs.2026.104519_bib0016","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). Bul\u00e1rio eletr\u00f4nico. Bras\u00edlia, DF: ANVISA, [n.d.]. Available at: https:\/\/consultas.anvisa.gov.br\/#\/bulario\/ Accessed May 18, 2026."},{"key":"10.1016\/j.xphs.2026.104519_bib0017","unstructured":"Pfizer, 2026. Diflucan\u00ae (fluconazole). Product Detail. Available at: https:\/\/www.pfizer.com\/products\/product-detail\/diflucan Accessed May 18, 2026."},{"key":"10.1016\/j.xphs.2026.104519_bib0018","unstructured":"Drugs.com. Fluconazole: Uses, Dosage, Side Effects, Warnings. Available at: https:\/\/www.drugs.com\/fluconazole.html. Accessed May, 18, 2026."},{"key":"10.1016\/j.xphs.2026.104519_bib0019","unstructured":"DrugBank Online. Fluconazole. DrugBank accession no. DB00196. Available at: https:\/\/www.drugbank.ca\/drugs\/DB00196 Accessed March 29, 2026."},{"key":"10.1016\/j.xphs.2026.104519_bib0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10973-009-0473-x","article-title":"Thermal characterization of the solid state and raw material fluconazole by thermal analysis and pyrolysis coupled to GC\/MS","volume":"100","author":"Moura","year":"2010","journal-title":"J Therm Anal Calorim"},{"key":"10.1016\/j.xphs.2026.104519_bib0021","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10847-010-9908-z","article-title":"Inclusion complexes of fluconazole with \u03b2-cyclodextrin: physicochemical characterization and in vitro evaluation of its formulation","volume":"70","author":"Yurtda\u015f","year":"2011","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"10.1016\/j.xphs.2026.104519_bib0022","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003088-199324010-00002","article-title":"Clinical pharmacokinetics of fluconazole","volume":"24","author":"Debruyne","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2026.104519_bib0023","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xphs.2026.104519_bib0024","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system","volume":"58","author":"Lindenberg","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2026.104519_bib0025","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1002\/jps.24181","article-title":"Biowaiver monograph for immediate-release solid oral dosage forms: fluconazole","volume":"103","author":"Charoo","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104519_bib0026","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/jphp.12411","article-title":"Risk assessment for extending the biopharmaceutics classification system-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric population","volume":"67","author":"Charoo","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2026.104519_bib0027","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1021\/acs.molpharmaceut.5b00135","article-title":"In vitro dissolution of fluconazole and dipyridamole in gastrointestinal simulator (GIS), predicting In vivo dissolution and drug-drug interaction caused by acid-reducing agents","volume":"12","author":"Matsui","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2026.104519_bib0028","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejps.2013.09.010","article-title":"Is the full potential of the biopharmaceutics classification system reached?","volume":"57","author":"Bergstr\u00f6m","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104519_bib0029","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2125.2010.03757.x","article-title":"Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the biopharmaceutic classification system","volume":"70","author":"Ramirez","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xphs.2026.104519_bib0030","article-title":"Classification of polymorphic forms of fluconazole in pharmaceuticals by FT-IR and FT-NIR spectroscopy","volume":"196","author":"Mansouri","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2026.104519_bib0031","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.10541","article-title":"Preparation and crystal characterization of a polymorph, a monohydrate, and an ethyl acetate solvate of the antifungal fluconazole","volume":"93","author":"Caira","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104519_bib0032","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/cg201005y","article-title":"New polymorphs of fluconazole: results from cocrystallization experiments","volume":"12","author":"Karanam","year":"2012","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2026.104519_bib0033","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1021\/acs.cgd.9b01066","article-title":"Impact of crystal structure and molecular conformation on the hydration kinetics of fluconazole","volume":"19","author":"Basford","year":"2019","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2026.104519_bib0034","doi-asserted-by":"crossref","first-page":"9950","DOI":"10.1039\/D0CC03157G","article-title":"A general method for cultivating single crystals from melt microdroplets","volume":"56","author":"Ou","year":"2020","journal-title":"Chem Comm"},{"key":"10.1016\/j.xphs.2026.104519_bib0035","article-title":"Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method","volume":"23","author":"Owoyemi","year":"2024","journal-title":"Sci Afr"},{"key":"10.1016\/j.xphs.2026.104519_bib0036","doi-asserted-by":"crossref","first-page":"o370","DOI":"10.1107\/S0108270111031155","article-title":"1:1 cocrystal of fluconazole with salicylic acid","volume":"67","author":"Kastelic","year":"2011","journal-title":"Acta Crystallog C"},{"key":"10.1016\/j.xphs.2026.104519_bib0037","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1107\/S1600536813003656","article-title":"Fluconazole-malonic acid (1\/1)","volume":"69","author":"Kastelic","year":"2013","journal-title":"Acta Crystallog E"},{"key":"10.1016\/j.xphs.2026.104519_bib0038","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1107\/S2053229614010195","article-title":"Hydrogen ADPs with Cu K\u03b1 data? Invariom and Hirshfeld atom modeling of fluconazole","volume":"70","author":"Orben","year":"2014","journal-title":"Acta Crystallog C"},{"key":"10.1016\/j.xphs.2026.104519_bib0039","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1021\/acs.cgd.0c00768","article-title":"Conformational change initiates dehydration in fluconazole monohydrate","volume":"20","author":"Basford","year":"2020","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2026.104519_bib0040","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1107\/S1600536810036329","article-title":"Fluconazolium picrate","volume":"66","author":"Dutkiewicz","year":"2010","journal-title":"Acta Crystallog E"},{"key":"10.1016\/j.xphs.2026.104519_bib0041","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3390\/pharmaceutics14112486","article-title":"Design, preparation, characterization and evaluation of five cocrystal hydrates of fluconazole with hydroxybenzoic acids","volume":"14","author":"Yu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104519_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133192","article-title":"Stabilization of supramolecular network of fluconazole drug polyiodide: synthesis, computational and spectroscopic studies","volume":"1263","author":"Ferjani","year":"2022","journal-title":"J Mol Struc"},{"key":"10.1016\/j.xphs.2026.104519_bib0043","unstructured":"Lo J.B., Mackay G.G., Puz W.F. UK Patent Application GB 2270051A, 1994."},{"key":"10.1016\/j.xphs.2026.104519_bib0044","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jps.2600841210","article-title":"Characterization of polymorphic forms of fluconazole using Fourier transform Raman spectroscopy","volume":"84","author":"Gu","year":"1995","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104519_bib0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0099-5428(08)60712-1","article-title":"Fluconazole","volume":"27","author":"Dash","year":"2001","journal-title":"Anal Prof Drug Subst Excip"},{"key":"10.1016\/j.xphs.2026.104519_bib0046","unstructured":"Kreidl J., Czibula L., Szantay C., et al. WO Patent, WO02\/076955 A1, 2002."},{"key":"10.1016\/j.xphs.2026.104519_bib0047","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1107\/S1600576719014092","article-title":"Mercury 4.0: from visualization to analysis, design and prediction","volume":"53","author":"Macrae","year":"2020","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.xphs.2026.104519_bib0048","unstructured":"Clegg W. CCDC 1951672: experimental crystal structure determination, 2019, DOI: 10.5517\/ccdc.csd.cc23hw5p"},{"key":"10.1016\/j.xphs.2026.104519_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.jct.2020.106243","article-title":"Experimental investigation of fluconazole: equilibrium solubility and sublimation","volume":"151","author":"Blokhina","year":"2020","journal-title":"J Chem Thermodyn"},{"issue":"2","key":"10.1016\/j.xphs.2026.104519_bib0050","first-page":"115","article-title":"Study of process induced polymorphic transformation in fluconazole drug","volume":"66","author":"Desai","year":"2009","journal-title":"Acta Pol Pharm"},{"key":"10.1016\/j.xphs.2026.104519_bib0051","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1248\/cpb.58.1243","article-title":"Solid-state carbon NMR characterization and investigation of intrinsic dissolution behavior of fluconazole polymorphs, anhydrate forms I and II","volume":"58","author":"Park","year":"2010","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.xphs.2026.104519_bib0052","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/03639040903358181","article-title":"Determination of factors affecting kinetics of solid-state transformation of fluconazole polymorph II to polymorph I using diffuse reflectance Fourier transform spectroscopy","volume":"36","author":"Obaidat","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2026.104519_bib0053","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpha.2012.05.007","article-title":"Solid-state characterization and impurities determination of fluconazole generic products marketed in Marocco","volume":"2","author":"Bourichi","year":"2012","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.xphs.2026.104519_bib0054","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0040-6031(02)00451-3","article-title":"Thermoanalytical study of polymorphic transformation in fluconazole drug","volume":"399","author":"Desai","year":"2003","journal-title":"Thermochim Acta"},{"key":"10.1016\/j.xphs.2026.104519_bib0055","unstructured":"BRASIL, Minist\u00e9rio da Sa\u00fade, RDC no 31 de 11 de Agosto de 2010. Available at: https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/anvisa\/2010\/res0031_11_08_2010.html Accessed April 02, 2026"},{"key":"10.1016\/j.xphs.2026.104519_bib0056","unstructured":"BRASIL, Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria, Nota T\u00e9cnica N\u00b0 003\/2013 \u2013 Vers\u00e3o 2.0 SNGPC. Available at: https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/fiscalizacao-e-monitoramento\/sngpc\/legislacao\/arquivos\/9172json-file-1 Accessed April 02, 2026"},{"key":"10.1016\/j.xphs.2026.104519_bib0057","series-title":"Fluconazole Monograph, Assay Method B","year":"2019"},{"key":"10.1016\/j.xphs.2026.104519_bib0058","first-page":"4859","volume":"5","year":"2007","journal-title":"Monographie Officielle du Fluconazole, Pharmacop\u00e9e europ\u00e9enne"},{"key":"10.1016\/j.xphs.2026.104519_bib0059","series-title":"Product Monographproducts","year":"2010"},{"key":"10.1016\/j.xphs.2026.104519_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/610427","article-title":"Development and validation of dissolution test for fluconazole capsules by HPLC and derivative UV spectrophotometry","volume":"2012","author":"C\u00f4rrea","year":"2012","journal-title":"Chromatogr Res Int"},{"key":"10.1016\/j.xphs.2026.104519_bib0061","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijpharm.2006.08.005","article-title":"Recrystallization of fluconazole using the supercritical antisolvent (SAS) process","volume":"328","author":"Park","year":"2007","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:05:27Z","timestamp":1791479127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0022354926003692"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104519","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solid state convergence to fluconazole monohydrate: Mechanochemical hydration, phase transitions, and solvent\u2011mediated conversion driving solubility","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104519"}}